Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Armata Pharmaceuticals (ARMP) Equity Average (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed Equity Average for 5 consecutive years, with $10.2 million as the latest value for Q3 2018.

  • Quarterly Equity Average rose 3.76% to $10.2 million in Q3 2018 from the year-ago period, while the trailing twelve-month figure was $10.2 million through Sep 2018, up 3.76% year-over-year, with the annual reading at $17.0 million for FY2017, 51.83% up from the prior year.
  • Equity Average hit $10.2 million in Q3 2018 for Armata Pharmaceuticals, down from $13.1 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $19.9 million in Q3 2016 to a low of -$28.3 million in Q1 2014.
  • Historically, Equity Average has averaged $6.5 million across 5 years, with a median of $10.2 million in 2018.
  • Biggest five-year swings in Equity Average: soared 5886.43% in 2016 and later tumbled 50.6% in 2017.
  • Year by year, Equity Average stood at $3.9 million in 2014, then surged by 263.57% to $14.2 million in 2015, then decreased by 1.5% to $14.0 million in 2016, then rose by 22.0% to $17.0 million in 2017, then plummeted by 40.31% to $10.2 million in 2018.
  • Business Quant data shows Equity Average for ARMP at $10.2 million in Q3 2018, $13.1 million in Q2 2018, and $19.5 million in Q1 2018.